# Vasopressors


## Indications

## Contraindications


+---------------+---------------+--------------------------------+--------------------------------------+
| Drug          | Noradrenaline | Vasopressin                    | Methylene Blue                       |
+===============+===============+================================+======================================+
| Overview      |               | Endogenous nonapeptide\        |                                      |
|               |               | cts on V~1~ and V~2~ receptors |                                      |
+---------------+---------------+--------------------------------+--------------------------------------+
|               |               | * Not a catecholamine\         | * Mesenteric vasoconstriction        |
|               |               | Works synergistically.         | * Coronary vasoconstriction\         |
|               |               | * Not affected by acidosis     | May lead to ischaemia.               |
|               |               | * Not pro-arrhythmic           | * Possibly â†‘ microcirculatory change |
|               |               | * Fluid retention              | * Hyponatraemia                      |
+---------------+---------------+--------------------------------+--------------------------------------+
| Disadvantages |               |                                | * MAO Inhibition                     |
+---------------+---------------+--------------------------------+--------------------------------------+


## Comparison

## Equipment

## Technique

## Complications

## Key Studies

* VAAST
* VANISH


---

## References
